UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea approves Olumiant pills for treatment of rheumatoid arthritis
The government has approved Olumiant (ingredient: baricitinib), an oral med...
by Lee Hye-seon
|
2017-12-12 11:50
라인
Huons wins patent for oral medication of clarithromycin
Huons, a subsidiary of Huons Global, said Tuesday that it has acquired a pa...
by Lee Han-soo
|
2017-12-12 11:41
라인
PCL shares rise despite regulator’s warning
Shares of PCL, a provider of in vitro diagnostic products, have risen again...
by Nam Doo-hyun
|
2017-12-12 11:02
라인
JW Pharma unveils trial result for target anticancer treatment
JW Pharmaceuticals said Monday that it has presented phase 1a/1b clinical t...
by Lee Han-soo
|
2017-12-11 16:55
라인
Pfizer pays most to doctors for overseas academic events
Among multinational pharmaceutical companies, Pfizer Korea paid the largest...
by So Jae-hyeon
|
2017-12-11 16:28
라인
Oscotec shares rebound on launch of US clinical trial
Shares of Oscotec rebounded on Monday on the company’s announcement that it...
by Nam Doo-hyun
|
2017-12-11 15:50
라인
Korea becomes 10th nation to join international medical device group
Korea has become an official member of the International Medical Device Reg...
by Marian Chu
|
2017-12-11 15:25
라인
ToolGen’s shares jump on gene therapy market expectations
With rising expectations for a rapid growth of gene therapy market, investo...
by Nam Doo-hyun
|
2017-12-11 15:16
라인
KIST finds nanomaterial that can break down cancer cell barrier
Researchers at Korea Institute of Science and Technology (KIST) have develo...
by Lee Han-soo
|
2017-12-11 15:11
라인
30,000 physicians protest 'Mooncare' on street rally
About 30,000 physicians stage a rally at the Daehanmun of Deoksugung, centr...
by Choi Gwang-seok
|
2017-12-11 15:02
라인
Free public cancer screening gets popular: survey
The number of adults getting free cancer screenings provided by the governm...
by Marian Chu
|
2017-12-11 13:21
라인
SNUBH diagnoses ovarian cancer with blood test
Researchers at Seoul National University Bundang Hospital (SNUBH) have deve...
by Lee Han-soo
|
2017-12-11 12:04
라인
MGmed to run world’s 1st postmortem DNA bank
MGmed, a Korean firm specializing in molecular diagnostic techniques for ge...
by Marian Chu
|
2017-12-08 17:11
라인
Toolgen wins German utility model for gene editing tool
Toolgen said Friday that it has completed the registration of two German ut...
by Lee Han-soo
|
2017-12-08 16:56
라인
Constitutional Court upholds ban on cord blood sales
The Constitutional Court ruled on Friday that the clause in the cord blood ...
by Lee Han-soo
|
2017-12-08 15:16
라인
Secrets of ezCaretech’s overseas expansion success
EZCaretech is a leading provider of medical IT services for hospitals. In p...
by Park Gi-taek
|
2017-12-08 15:09
라인
Menstrual cups approved for 1st time in Korea
The Ministry of Food and Drug Safety said Thursday it approved FemmyCycle a...
by Marian Chu
|
2017-12-08 14:56
라인
[Startups to Watch]‘Big data will determine pharmaceutical industry’s future’
“Korea drugmakers can make giant leaps with big data.”Yi Hong-gi, CEO of Co...
by Lee Han-soo
|
2017-12-08 11:46
라인
Health-welfare spending in 2018 grows 9.5%
The Ministry of Health and Welfare’s budget for 2018 has been set at 63.1 t...
by Marian Chu
|
2017-12-07 19:04
라인
Chairman Lee vows to grow MGmed as ‘new drug developer’
Lee Wang-jun, chairman of Myongji Hospital, made headlines in late October ...
by Song Soo-youn
|
2017-12-07 15:28
-
이전
251
252
253
254
255
256
257
258
259
260
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top